3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Neuroblastoma
1
Neoplasms
1
Lung Neoplasms
1
Interventions
pembrolizumab
603
Cyclophosphamide
545
Magnetic Resonance Spectroscopy
527
Radiotherapy
513
Specimen Handling
505
Nivolumab
411
Cisplatin
381
Carboplatin
369
Biopsy
305
Blood Specimen Collection
304
Radiosurgery
290
Paclitaxel
281
Gemcitabine
271
Surveys and Questionnaires
269
Standard of Care
267
fludarabine
263
Drug Therapy
263
Dexamethasone
263
Bevacizumab
252
venetoclax
251
Oxaliplatin
209
Capecitabine
199
Rituximab
198
Radiation
191
Ipilimumab
188
Fluorouracil
188
durvalumab
185
Doxorubicin
178
Etoposide
177
atezolizumab
172
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Pregnancy Tests
×
1 year
×
Clear all
NCT06620835
2026-04-29
OPTALK
Groupe Francais De Pneumo-Cancerologie
Phase 2
Recruiting
45 enrolled
NCT02780128
2026-03-10
NEPENTHE
Children's Hospital of Philadelphia
Phase 1
Terminated
66 enrolled